Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,129 across all filing types
Latest filing 2022-04-13 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
本公司受邀參加由臺灣證券交易所及寬量國際共同主辦之線上法說會「11th Taiwan CEO Week」
Regulatory Filings Classification · 90% confidence The document is a brief announcement about the company (1707 葡萄王) participating in an online investor conference hosted by the Taiwan Stock Exchange and another organization. It specifies the date and time of the event and mentions that detailed financial information can be found elsewhere. The document is short (699 characters) and does not contain any financial statements or detailed financial analysis. It is essentially a notice about an upcoming investor presentation event rather than the presentation itself or a detailed report. Therefore, it fits best as an Investor Presentation (IP) announcement or a Regulatory Filing (RNS). However, since it is announcing participation in an investor presentation event rather than providing the presentation materials, the best classification is Regulatory Filings (RNS) as a general announcement about the event.
2022-04-13 Chinese
111年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (葡萄王) reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no earnings highlights, no meeting materials, and no legal or regulatory narrative. The document is very short (602 characters) and appears to be a routine regulatory disclosure of financial guarantees and loans status. It does not fit into detailed report categories like Annual Report, Interim Report, or Earnings Release. It is not a certification or announcement of a report. Given the nature and brevity, this is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory disclosures that do not fit other categories.
2022-04-11 Chinese
111年3月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a revenue summary report for a company named 葡萄王 for the period 民國111年03月 (March 2022). It contains monthly and cumulative net operating revenue figures with comparisons to the previous year. The document is short (771 characters) and primarily provides summarized financial data without detailed financial statements or analysis. It does not appear to be a full annual or interim report, nor an earnings release or management discussion. It is a brief financial summary report, typical of a Fund Information / Factsheet (FS) which provides key company financial facts in a concise format.
2022-04-11 Chinese
代重要子公司上海葡萄王企業有限公司公告，因應新冠肺炎 疫情影響，配合當地政府防疫工作延長封控管理。
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (1707 葡萄王) regarding an operational update of its subsidiary due to COVID-19 related lockdown measures. It states the impact on production and shipment but explicitly mentions no significant financial impact. The document is brief (699 characters) and does not contain any financial statements, detailed financial data, or regulatory filings such as annual or quarterly reports. It is an operational update related to a subsidiary's status, which fits best under general regulatory announcements. There is no indication of board changes, voting results, or other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-04-07 Chinese
111年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is not a report publication announcement or a certification. Given the detailed insider shareholding data, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives.
2022-04-07 Chinese
111年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors and senior management, showing their current and initial shareholdings, pledged shares, and related party holdings. It is a disclosure of insider shareholdings and changes, typical of a director's dealing or insider transaction report. There is no indication of financial results, meeting materials, or regulatory certifications. The document length is 2672 characters, which is relatively short but contains detailed insider shareholding data. Therefore, it fits best under the category of Director's Dealing (DIRS).
2022-04-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.